AU-19820

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAU-19820
Drug Alias NameAU-19820
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionProbable global transcription activator SNF2L2 inhibitorsProteolysis
TargetsProbable global transcription activator SNF2L2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurigene
China Registration ClassN/A

Develop Information

Active CompaniesAurigene
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A